Indocyanine Green Angiography Use in Breast Reconstruction
| Autor: | Austin D. Chen, Bernard T. Lee, Samuel J. Lin, Anmol S. Chattha, Alexandra Bucknor |
|---|---|
| Rok vydání: | 2018 |
| Předmět: |
Adult
Indocyanine Green medicine.medical_specialty Adolescent Databases Factual Mammaplasty medicine.medical_treatment Breast surgery 030230 surgery Surgical Flaps Young Adult 03 medical and health sciences chemistry.chemical_compound 0302 clinical medicine Outcome Assessment Health Care medicine Humans Breast Healthcare Cost and Utilization Project Mastectomy Aged Fluorescent Dyes Retrospective Studies Aged 80 and over medicine.diagnostic_test business.industry Angiography Retrospective cohort study Health Care Costs Middle Aged United States Logistic Models Debridement chemistry 030220 oncology & carcinogenesis Female Surgery Radiology Breast reconstruction business Indocyanine green |
| Zdroj: | Plastic and Reconstructive Surgery. 141:825-832 |
| ISSN: | 0032-1052 |
| Popis: | BACKGROUND Indocyanine green angiography has gained popularity in breast reconstruction for its ability to assess mastectomy skin and tissue flap viability. The authors aim to analyze trends and outcomes associated with indocyanine green angiography use in breast reconstruction. METHODS Using 2012 to 2014 data from the Healthcare Cost and Utilization Project National Inpatient Sample, Agency for Healthcare Research and Quality, the authors identified breast reconstructions performed with or without indocyanine green angiography use. Trends over time were assessed using the Cochran-Armitage test. Outcomes were assessed using logistic regression and generalized linear modeling. RESULTS Over the study period, 110,320 patients underwent breast reconstruction: 107,005 (97.0 percent) without and 3315 (3.0 percent) with indocyanine green angiography use. Usage increased over time: 750 patients (1.9 percent) in 2012, increasing to 1275 patients (3.7 percent) in 2013 (p < 0.001). Smokers (p = 0.018), hypertensive patients (p = 0.046), obese patients (p < 0.001), and those with a higher comorbidity index (p < 0.001) were more likely to undergo indocyanine green angiography. Autologous reconstruction was more frequently combined with its use compared with tissue expander reconstruction (4.5 percent versus 2.1 percent; p < 0.001). There was a significant increase in the odds of debridement associated with its use (OR, 1.404; p < 0.001; 95 percent CI, 1.201 to 1.640). CONCLUSIONS Indocyanine green angiography use in breast reconstruction has increased in recent years and is associated with higher debridement rates. These rates may indicate changing trends for clinicians when deciding whether to debride tissue during breast reconstruction. CLINICAL QUESTION/LEVEL OF EVIDENCE Therapeutic, III. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|